Tirzepatide and Adderall, though designed for very different conditions, can both impact your body over extended periods
With our nutritional guidance, we help make sure you are eating the right foods to support a diverse and healthy gut microbiome
Absolute Contraindications Active malignancy Pregnancy and lactation Severe hypoglycemia disorders Known hypersensitivity to IGF-1 Active proliferative retinopathy Relative Contraindications Diabetes mellitus Renal impairment Cardiac impairment History of hyperplasia Family history of certain cancers Severe hepatic impairment Dosing & Administration Starting Dose 2050 mcg/day subcutaneously Begin at the lower end for sensitive patients Assess tolerance for 12 weeks before titration Therapeutic Range 50120 mcg/day for most indications Maximum dose: 200 mcg/day Individualize dosing based on response and tolerance Cycling Protocol 46 weeks on therapy 4 weeks off therapy Helps prevent receptor desensitization Supports long-term efficacy Administration Guidelines Hypoglycemia Prevention: Always administer IGF-1 LR3 with or shortly after carbohydrate-containing meals

Other research is showing improvements with damaged nerve tissue, brain injury, seizure, stroke, neurodegenerative diseases such as Alzheimer's Disease, Muscular Dystrophy, Multiple Sclerosis, Parkinson's Disease, spinal cord injury, and neuropathies
Springer, 979994
We dont yet know the long-term effects for Lipedema While GLP-1s have been well-studied for diabetes and obesity, research specifically in Lipedema is still emerging